Last updated: July 9, 2024
Sponsor: National Cheng-Kung University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Fast Heart Rate (Tachycardia)
Heart Disease
Cardiac Disease
Treatment
Lidocaine
Clinical Study ID
NCT06497296
B-ER-111-218
Ages 20-90 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Eligible participants included patients aged ≥ 20 years who scheduled EGD from OPDfor dyspepsia, peptic ulcer disease, GERD, subepithelial lesion evaluation, anddiarrhea
Exclusion
Exclusion Criteria:
GI bleeding
endoscopic submucosal dissection due to prolonged scheduled procedure time
patients from emergency department or ward
Study Design
Total Participants: 160
Treatment Group(s): 1
Primary Treatment: Lidocaine
Phase:
Study Start date:
January 01, 2023
Estimated Completion Date:
December 31, 2024
Study Description
Connect with a study center
Hsueh-Chien Chiang
Tainan, Other (Non U.s.) 704
TaiwanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.